GENSCRIPT BIO
Biotechnology · Healthcare
CFO
1 appearance
Latest appearance 2026-03-16
Phil Zhou
CFO
GENSCRIPT BIO
Equibles does not estimate personal net worth.
About Phil Zhou
Phil Zhou is recorded as CFO at GENSCRIPT BIO. Phil Zhou has spoken on 1 earnings call across 1 company, most recently for GENSCRIPT BIO on March 16, 2026. GENSCRIPT BIO is classified in the Biotechnology industry within the Healthcare sector.
Phil Zhou on recent calls
“Joining me on the call today are Mr. Robin Meng, Chairman of the Board, Ms. Sherry Sao, Rotating CEO of Transcript, Dr. Ray Tseng, President of Transcript Life Science Group, Dr. I.C. Bai, General Manager of Bessign, Mr. Alan Guo, CEO of Prebalt.”
Affiliation history
-
GENSCRIPT BIO
CFO
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
2025 Annual Results Conference
GENSCRIPT BIO